Search

everythinglearnresearchcommunity

for

Search:↓

The method accurately measures testosterone metabolites with high sensitivity and low environmental impact.

An 11-year-old girl's hair regrew after treating her thyroid condition with carbimazole.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

RXR agonists may promote hair growth in humans.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

RXR and RAR proteins in skin may help with cell growth, hair growth, and gland function.

A new method efficiently creates biaryl N-oxides with potential for cancer treatment and drug development.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Sulfur-35 can be used to track hair growth and past exposure.

RXR-alpha is strongly expressed in both normal and psoriatic skin and may help in skin cell differentiation and hair growth.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Thyroid ultrasounds are essential but need skill and experience for accurate results.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

The new LC-MS/MS method is more accurate and reliable than traditional immunoassays for measuring steroids in serum.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Borderline newborn screening results should be carefully evaluated to prevent delayed diagnosis of thyroid issues.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

A new compound, 3a, effectively fights prostate cancer better than finasteride.